Lilly Completes Acquisition of DICE Therapeutics
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/20/2026
- Wall Street gains as healthcare stocks rally, oil prices fall
- Brent hits five-month high as attacks on ships, Saudi sites fuel supply worries
- Loop Capital downgrades Apple, sees no recovery of cut iPhone shipments
- Wells Fargo says S&P 500 buy signal emerges as investors turn excessively bearish
- ByteDance, Alibaba and Tencent order $35 billion of Nvidia chips: Reuters
- Cerebras Systems falls as TD Cowen cuts price target
- Nasdaq climbs as chip and AI-linked stocks bounce back
- Flutter Entertainment to cut up to 1,400 jobs amid UK tax increases
- 3M issues warrant to Amazon in $6B data center product deal
- Glass House Brands posts Q3 revenue of $56.8M, board member exits
Eli Lilly & Co. (LLY) upgraded at Jefferies - sees near-term revenue and EPS upside
August 9, 2023 11:00 AM EDTEli Lilly & Co. (NYSE: LLY) was raised to Buy from Hold at Jefferies on Wednesday, with analyst Akash Tewari raising the price target to $615 per share from $430.
The upgrade follows two positive data points for the pharmaceutical company. Tewari explained that "SELECT showed... More



